Cartesian Therapeutics, Inc. (RNAC): Free Cash Flow
-$79.39M
Year ended 2025-12-31
-$78.61M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$79.39M | n/m | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | -$32.77M | n/m | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | -$51.37M | n/m | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | -$32.83M | n/m | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | -$61.47M | n/m | 2024-03-07, From 2021-01-01 |
| 2020-12-31 | $34.07M | n/m | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | -$51.48M | n/m | 2022-03-10, From 2019-01-01 |
| 2018-12-31 | -$60.05M | n/m | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | -$52.76M | n/m | 2020-03-12, From 2017-01-01 |
| 2016-12-31 | -$20.34M | n/m | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | -$23.63M | n/m | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | -$12.91M | n/a | 2017-03-28, From 2014-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$79.39M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$133.44M | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.50M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$29.83M | n/m |
| Lipocine Inc. (LPCN) | 2024-12-31 | -$1.31M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $88.9K | n/m |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | -$8.34M | n/m |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | -$18.80M | n/m |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | -$7.93M | n/a |
Compare RNAC, UPB, GOVX, CAMP side by side · Screen every company in Pharmaceutical Preparations ↗